Corcept Therapeutics CORT
NASDAQ CORT
$116.23 +2.20 (+1.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2011)

Updated

Corcept Therapeutics (CORT) recorded Interest & Investment Income of $3,000 in FY2011, down 99.8% from $1.5 million in FY2010.

Analysis

Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2011) Analysis & Trends

  • Per Business Quant data, CORT's Interest & Investment Income was $1.5 million in FY2010 and $101,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Corcept Therapeutics 12.56 Bn 11.12 Bn 252.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 3,000.00
Jun 30, 2011 -1,000.00
Mar 31, 2011 2,000.00
Dec 31, 2010 738,000.00
Sep 30, 2010 4,000.00
Jun 30, 2010 753,000.00
API Access

Corcept Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CORT&period=max&api_key=YOUR_API_KEY